PRTA Q2 2023 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+206.3% YoY

Gross Profit

-$52M-1293.7% margin

Operating Income

-$67M-1654.7% margin

Net Income

-$55M-1358.4% margin

EPS (Diluted)

$-1.03

QoQ Revenue Growth

+85.3%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$46M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$721M

Total Liabilities

$139M

Stockholders' Equity

$582M

Cash & Equivalents

$659M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$1M	+206.3%
Gross Profit	-$52M	-$30M	-71.8%
Operating Income	-$67M	-$43M	-53.9%
Net Income	-$55M	-$41M	-32.4%

Revenue Segments

US Rights and Global Rights

$85M54%

Collaboration Program, US Rights

$67M43%

Collaboration

$4M3%